| SKŘIČKOVÁ, Jana, Marcela TOMÍŠKOVÁ, Irena VAŠUTOVÁ, Bohdan KADLEC, Jana KAPLANOVÁ, Lenka BABIČKOVÁ, Pavel TURČÁNI, Tomáš NEBESKÝ, Leoš KŘEN a Lucie BUREŠOVÁ. Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients. Online. European Respiratory Journal. Berlin: 18 th ERS Annual Congress, 2008, roč. 32, supl 52, s. 1399-1401. ISSN 0904-1850. [citováno 2024-04-24] |
Další formáty:
BibTeX
LaTeX
RIS
@article{784654,
author = {Skřičková, Jana and Tomíšková, Marcela and Vašutová, Irena and Kadlec, Bohdan and Kaplanová, Jana and Babičková, Lenka and Turčáni, Pavel and Nebeský, Tomáš and Křen, Leoš and Burešová, Lucie},
article_location = {Berlin},
article_number = {supl 52},
keywords = {non small cell lung cancer; clinical analysis; erlotinib},
language = {eng},
issn = {0904-1850},
journal = {European Respiratory Journal},
title = {Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients},
volume = {32},
year = {2008}
}
TY - JOUR
ID - 784654
AU - Skřičková, Jana - Tomíšková, Marcela - Vašutová, Irena - Kadlec, Bohdan - Kaplanová, Jana - Babičková, Lenka - Turčáni, Pavel - Nebeský, Tomáš - Křen, Leoš - Burešová, Lucie
PY - 2008
TI - Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients
JF - European Respiratory Journal
VL - 32
IS - supl 52
SP - 1399
EP - 1399
PB - 18 th ERS Annual Congress
SN - 09041850
KW - non small cell lung cancer
KW - clinical analysis
KW - erlotinib
N2 - Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients An analysis is presented of clinical factors in relationship to the treatment with erlotinib in non-small cell lung cancer.
ER -
SKŘIČKOVÁ, Jana, Marcela TOMÍŠKOVÁ, Irena VAŠUTOVÁ, Bohdan KADLEC, Jana KAPLANOVÁ, Lenka BABIČKOVÁ, Pavel TURČÁNI, Tomáš NEBESKÝ, Leoš KŘEN a Lucie BUREŠOVÁ. Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patiients. Online. \textit{European Respiratory Journal}. Berlin: 18 th ERS Annual Congress, 2008, roč.~32, supl 52, s.~1399-1401. ISSN~0904-1850. [citováno 2024-04-24]
|
